Skip to content

Construction and evaluation of chronic disease management model of traditional Chinese medicine for rheumatoid arthritis

Construction and evaluation of chronic disease management model of traditional Chinese medicine for rheumatoid arthritis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070873
Enrollment
Unknown
Registered
2023-04-25
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

Observation group:Chinese and Western medicine basic treatment + Chinese medicine chronic disease management
Control group:Basic treatment of Chinese and Western medicine

Sponsors

The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meets the 2010 ACR/EULAR diagnostic criteria for RA; (2) Conforming to the diagnostic efficacy criteria for traditional Chinese medicine syndrome of Bi syndrome; (3) Age 18-70 years old, regardless of gender; (4) Willing to cooperate and able to truthfully complete clinical information questionnaires; (5) The patient understands the significance of participating in this topic and the potential risks in clinical research, voluntarily participates in this study, and signs an informed consent form. (6) The patient has a clear consciousness and clear language expression, no mental or neurological diseases and other diseases that hinder psychological test, and can cooperate to complete the investigation. (7) Patients have cognitive and literacy abilities, can use smartphones on their own or with the help of others, and can actively cooperate to ensure the continuity of treatment and regular follow-up.

Exclusion criteria

Exclusion criteria: (1) Combined with serious primary diseases of the cardiovascular, cerebrovascular, hepatic, renal, endocrine and hematopoietic systems and those with overlapping other rheumatic immune diseases: such as gouty arthritis, systemic lupus erythematosus, dry syndrome, etc; (2) Patients who are pregnant, lactating or have reproductive requirements; (3) Patients with serious mental illnesses such as schizophrenia, epilepsy, or critical conditions that prevent them from cooperating to complete the test; (4) Patients with a recent history of surgery or those who intend to undergo surgery in the near future; (5) Patients with a history of alcohol or drug abuse or neuropsychiatric abnormalities (epilepsy, depression, etc.)

Design outcomes

Primary

MeasureTime frame
Health Assessment Questionnaire(HAQ);Quality of life for patients with rheumatoid arthritis;Based on 28 joint disease activity scores;

Secondary

MeasureTime frame
TCM Symptom Score;Number of painful joints;Number of swollen joints;Pain visual simulation score;Patient's own overall assessment of disease activity(PGA);Physician's overall assessment of disease activity(MDGA);Clinical Disease Activity Index (CDAI);Medication Adherence;ESR;C-reactive protein;Follow-up rate;

Countries

China

Contacts

Public ContactPu Yongbin

Yunnan Provincial Hospital of Traditional Chinese Medicine

75173427@qq.com+86 13987190559

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026